Loading... Please wait... Loading... Please wait...
ESTIMATED
05/06/2024
05/06/2024
(AS OF MARCH 31)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 2 | $0.01 | $0.01 | $0.01 |
| Q2 2024 | 9 | $0.02 | $0.06 | $0.05 |
| Q3 2024 | 3 | $0.04 | $0.04 | $0.04 |
| Q4 2024 | 4 | $0.04 | $0.04 | $0.04 |
| Q1 2025 | 6 | $0.09 | $0.09 | $0.09 |
| Q2 2025 | 4 | $0.10 | $0.10 | $0.10 |
| Q3 2025 | 4 | $0.10 | $0.10 | $0.10 |
| Q4 2025 | 6 | $0.11 | $0.11 | $0.11 |
| Q1 2026 | 6 | $0.22 | $0.22 | $0.22 |
| Q2 2026 | 3 | $0.23 | $0.23 | $0.23 |
| Q3 2026 | 3 | $0.24 | $0.24 | $0.24 |
| Q4 2026 | 6 | $0.25 | $0.25 | $0.25 |
Hims & Hers Health, Inc. last posted its earnings results on Monday, May 6th, 2024. The company reported $0.05 earnings per share for the quarter, topping analysts' consensus estimates of $0.012 by $0.038. The company had revenue of 278.17 M for the quarter and had revenue of 872.00 M for the year. Hims & Hers Health, Inc. has generated $0 earnings per share over the last year ($-0.11 diluted earnings per share) and currently has a price-to-earnings ratio of -1860.33. Hims & Hers Health, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 5th, 2024 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/06/2024 | Q1 2024 | $0.01 | $0.05 | 0.04 | $270.37 M | $278.17 M | 02/26/2024 | Q4 2023 | $0.00 | $0.01 | 0 | $246.47 M | $246.62 M | 11/06/2023 | Q3 2023 | -$0.03 | -$0.04 | -0 | $226.70 M | 08/07/2023 | Q2 2023 | -$0.06 | -$0.03 | 0.03 | $207.91 M | 05/08/2023 | Q1 2023 | -$0.06 | -$0.05 | 0.01 | $179.08 M | $190.77 M | 02/27/2023 | Q4 2022 | -$0.07 | -$0.05 | 0.02 | $161.17 M | $167.20 M | 11/07/2022 | Q3 2022 | -$0.11 | -$0.09 | 0.02 | $144.84 M | 08/08/2022 | Q2 2022 | -$0.10 | -$0.10 | 0 | $113.56 M | 05/09/2022 | Q1 2022 | -$0.09 | -$0.08 | 0.01 | $101.31 M | 02/24/2022 | Q4 2021 | -$0.15 | $76.79 M | $84.70 M | 11/10/2021 | Q3 2021 | -$0.14 | -$0.08 | 0.06 | $70.53 M | $74.17 M | 08/11/2021 | Q2 2021 | -$0.16 | -$0.05 | 0.11 | $56.49 M | $60.69 M | 05/17/2021 | Q1 2021 | -$0.15 | -$0.34 | -0.19 | $52.31 M | 03/22/2021 | Q4 2020 | -$0.07 | $37.00 M | $41.47 M | 11/12/2020 | Q3 2020 | -$0.16 | $41.32 M | 08/13/2020 | Q2 2020 | -$0.03 | $35.90 M | 05/13/2020 | Q1 2020 | -$0.17 | $30.06 M | 03/27/2020 | Q4 2019 | -$0.36 | $24.77 M | 11/12/2019 | Q3 2019 | $0.00 | $0 |
|---|
A. Hims & Hers Health, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 5th, 2024 based off last year's report dates.
A. In the previous quarter, Hims & Hers Health, Inc. (NYSE:HIMS) reported $0.05 earnings per share (EPS) to beat the analysts' consensus estimate of $0.012 by $0.038.
A. The conference call for Hims & Hers Health, Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for Hims & Hers Health, Inc.'s latest earnings report can be read online.
A. Hims & Hers Health, Inc. (NYSE:HIMS) has a recorded annual revenue of $872.00 M.
A. Hims & Hers Health, Inc. (NYSE:HIMS) has a recorded net income of $872.00 M. Hims & Hers Health, Inc. has generated $-0.11 earnings per share over the last four quarters.
A. Hims & Hers Health, Inc. (NYSE:HIMS) has a price-to-earnings ratio of -1860.33 and price/earnings-to-growth ratio is -28.35.
